Skip to main content
AI Driven Precision Extraction

Unlocking Maximum Value from Every Tissue Slide

We preserve the connection between what the pathologist sees and what's measured at the molecular level.

Variant Detection

Bulk Extraction vs. QuantumCyte

TP53 Exon 5
Not detected
QuantumCyte
0.00%
APC Exon 16
Not detected
QuantumCyte
0.00%

The QuantumCyte Solution

Sample purity is critical for molecular testing. Target molecules (DNA, RNA, proteins) from cancer cells can be contaminated by other tissue, leading to false negatives and failed tests.

High-precision tissue enrichment increases sample purity, improving signal-to-noise for more confident molecular testing.

Trusted by leading hospitals and pharmaceutical teams

  • AstraZeneca
  • Roche
  • Merck
  • Mayo Clinic
  • Promega
  • Singapore General Hospital
Features

Core capabilities working in concert

QCPRECISE™ combines machine learning, precision mask printing, and automation into a single integrated workflow. Each component builds on the last to transform tissue into actionable molecular data.

AI-guided annotation

Machine learning finds the tissue that matters, marking regions with the precision solid tumor molecular testing demands.

Software-defined masking

Digital annotations become physical masks, printed directly onto slides at micron accuracy without deviation or drift.

Precision Enrichment

Lysis and purification from enriched tissue yield high-purity DNA, RNA, and protein ready for analysis.

How It Works

QCPRECISE™: AI, Automation, and Precision Drive Results

QCPRECISE integrates seamlessly into your FFPE tissue workflows. It transforms any annotated slide into a molecularly precise sample in five simple steps:

01

Tumor Identification

Manual or AI driven tumor annotations.

Identify tumor
02

Digital Mask Generation

Our software utilizes AI and computer vision to translate annotations to a printable mask file.

Digital mask generation
03

Tumor Masking

Mask file is inkjet printed on tissue to leave only tumor cells for extraction.

Tumor masking
04

Tumor Extraction

Tumor cells are lysed for DNA or RNA purification.

Tumor extraction
05

Molecular Testing

Extracted DNA or RNA is sequenced, leading to a higher signal to noise ratio.

Variant DetectionVAF SIGNAL
Two lab scientists in coats and safety glasses loading a tissue slide into the QCPRECISE instrument
Impact

What QuantumCyte delivers to your labs

The QCPRECISE™ platform selectively isolates the most relevant regions of tissue prior to molecular analysis, improving signal quality without changing downstream assays. The result is more reliable data, higher sensitivity, and better-informed decisions across research and clinical workflows at scale.

Increase signal-to-noise compared to manual microdissection
Compatible with tumor-insufficient samples
Generate cleaner, more actionable molecular data
Accelerate discovery and clinical advancement
Integrates directly into most digital pathology platforms without disruption

What precision tissue enrichment makes possible.

QCPRECISE™ delivers the precision and scale that modern molecular testing requires. Micron-level accuracy, seamless integration, and consistently pure samples transform how labs extract value from tissue.
Tissue with the region of interest annotated by AIPrecision mask printed onto the tissue
Annotated tissueMask printed on tissue

High precision at scale.

QCPRECISE™ ensures only the tissue that matters reaches your analysis.

Precision mask printed onto the tissueTissue after on-slide lysis of the targeted region
Mask printed on tissueTissue after lysis

Pure samples, reliable results.

High cellular purity DNA, RNA, and protein extraction enables confident downstream analysis.

Proven results

From labs transforming their workflows.

Without precise tumor enrichment this patient would have been denied a life-extending therapy.

Dr. Lim Kiat Hon (Tony)Dr. Lim Kiat Hon (Tony)Chairman, Division of Pathology, Singapore General Hospital

QuantumCyte's methodology allows for integration of spatial, molecular, and AI-derived quantitative pathologic data.

Dr. Rish PaiDr. Rish PaiProfessor, Laboratory Medicine & Pathobiology, University of Toronto

This is a game changer: reducing costs, accelerating research, and producing cleaner data to uncover mechanistic insights and evaluate the efficacy of novel compounds.

ExecutiveExecutiveTop 10 Pharma

Questions

Everything you need to know about QCPRECISE™ and how it integrates into your workflow.

Ready to see it work?

Request a demo of QCPRECISE™ and learn how QuantumCyte solves your tissue enrichment challenges.